Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Annexon Biosciences Stock

Q: How to sell Annexon Biosciences stock?

If you hold private company shares of Annexon Biosciences - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Annexon Biosciences stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

annexonbio.comHealthcare / BioTech & PharmaFounded: 2011Funding to Date: $154MM

Annexon is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain.

Buy or sell Annexon Biosciences stockLearn more about Annexon Biosciences IPO

OverviewFinancingsValuation

Enterprise Value

Access Annexon Biosciences’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Annexon Biosciences.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Jennifer Lew

Chief Financial Officer

Ted Yednock Ph.D

Chief Scientific Officer & Executive Vice President

Sanjay Keswani

Chief Medical Officer

Douglas Love JD

Chief Executive Officer, President & Board Member

Lesley Stolz Ph.D

Chief Business Officer

Board Members

Carol Gallagher

New Enterprise Associates

Giovanni Ferrara

Novartis Venture Fund

Stacie Weninger Ph.D

Emmett Cunningham Ph.D

Blackstone Life Sciences

Douglas Love JD

Frank Torti MD

New Enterprise Associates

Ricky Sun Ph.D

Bain Capital

William Young

Blackstone Life Sciences

Campbell Murray MD

Novartis Venture Fund

Muneer Satter JD

Satter Foundation

Thomas Wiggans

Annexon Biosciences stock FAQs

Can you buy Annexon Biosciences stock?

As Annexon Biosciences is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Annexon Biosciences, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Annexon Biosciences stock?

To invest in a private company like Annexon Biosciences through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Annexon Biosciences stock?

Yes, you may be able to sell your Annexon Biosciences stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Annexon Biosciences stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Annexon Biosciences stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Annexon Biosciences a public company?

No, Annexon Biosciences is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Annexon Biosciences’ stock price?

Annexon Biosciences is a privately held company and therefore does not have a public stock price. However, you may access Annexon Biosciences’ private market stock price with Forge Data.

What is Annexon Biosciences’ stock ticker symbol?

Annexon Biosciences does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

FinSMEs 06/23/2016

Biopharmaceutical Company Annexon Biosciences Closes $44M Series B Funding |FinSMEs

Annexon Biosciences, a South San Francisco, CA-based biopharmaceutical company developing classical complement pathway inhibitors to treat neurodegenerative disorders, closed $44m Series B financing round. The round was led by new investor New Enterprise Associates (NEA), with participation from Correlation Ventures and existing investors Novartis Venture Fund, Clarus, and Satter Investment Management, LLC. In conjunction with …

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.